(Q40288176)

English

Efficacy and safety of emtricitabine/tenofovir alafenamide (FTC/TAF) vs. emtricitabine/tenofovir disoproxil fumarate (FTC/TDF) as a backbone for treatment of HIV-1 infection in virologically suppressed adults: subgroup analysis by third agent of a r

scientific article published on 17 March 2017

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28303753%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

Efficacy and safety of emtricitabine/tenofovir alafenamide (FTC/TAF) vs. emtricitabine/tenofovir disoproxil fumarate (FTC/TDF) as a backbone for treatment of HIV-1 infection in virologically suppressed adults: subgroup analysis by third agent of a randomized, double-blind, active-controlled phase 3 trial<sup/> (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28303753%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Adriano Lazzarin

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28303753%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

Michael E Abram

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28303753%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

Yazdan Yazdanpanah

2

object named as

Yazdan Yazdanpanah

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28303753%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

author name string

Frank A Post

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28303753%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

Gabriel Schembri

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28303753%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

Jacques Reynes

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28303753%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

Franco Maggiolo

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28303753%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

Mingjin Yan

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28303753%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

Cecilia Tran-Muchowski

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28303753%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

Andrew Cheng

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28303753%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

Martin S Rhee

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28303753%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

language of work or name

1 reference

based on heuristic

inferred from title

publication date

17 March 2017

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28303753%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

HIV Clinical Trials

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28303753%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

18

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28303753%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28303753%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

135-140

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28303753%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

copyright license

Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International

17 March 2017

1 reference

https://api.crossref.org/v1/works/10.1080/15284336.2017.1291867

copyright status

1 reference

April 2022 Public Data File from Crossref

Tenofovir-associated kidney toxicity in HIV-infected patients: a review of the evidence

1 reference

https://api.crossref.org/works/10.1080%2F15284336.2017.1291867

21 January 2018

Tenofovir-associated Fanconi syndrome: review of the FDA adverse event reporting system

1 reference

https://api.crossref.org/works/10.1080%2F15284336.2017.1291867

21 January 2018

Randomized comparison of renal effects, efficacy, and safety with once-daily abacavir/lamivudine versus tenofovir/emtricitabine, administered with efavirenz, in antiretroviral-naive, HIV-1-infected adults: 48-week results from the ASSERT study

1 reference

https://api.crossref.org/works/10.1080%2F15284336.2017.1291867

21 January 2018

Bone mineral density and fractures in antiretroviral-naive persons randomized to receive abacavir-lamivudine or tenofovir disoproxil fumarate-emtricitabine along with efavirenz or atazanavir-ritonavir: Aids Clinical Trials Group A5224s, a substudy o

1 reference

https://api.crossref.org/works/10.1080%2F15284336.2017.1291867

21 January 2018

Chronic administration of tenofovir to rhesus macaques from infancy through adulthood and pregnancy: summary of pharmacokinetics and biological and virological effects.

1 reference

https://api.crossref.org/works/10.1080%2F15284336.2017.1291867

21 January 2018

Antiviral activity, safety, and pharmacokinetics/pharmacodynamics of tenofovir alafenamide as 10-day monotherapy in HIV-1-positive adults

1 reference

https://api.crossref.org/works/10.1080%2F15284336.2017.1291867

21 January 2018

Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised, double-blind, phase 3, non-inferiority trials

1 reference

https://api.crossref.org/works/10.1080%2F15284336.2017.1291867

21 January 2018

Brief Report: A Randomized, Double-Blind Comparison of Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate, Each Coformulated With Elvitegravir, Cobicistat, and Emtricitabine for Initial HIV-1 Treatment: Week 96 Results

1 reference

https://api.crossref.org/works/10.1080%2F15284336.2017.1291867

21 January 2018

Switching from tenofovir disoproxil fumarate to tenofovir alafenamide in antiretroviral regimens for virologically suppressed adults with HIV-1 infection: a randomised, active-controlled, multicentre, open-label, phase 3, non-inferiority study

1 reference

https://api.crossref.org/works/10.1080%2F15284336.2017.1291867

21 January 2018

Switching to Tenofovir Alafenamide, Coformulated With Elvitegravir, Cobicistat, and Emtricitabine, in HIV-Infected Patients With Renal Impairment: 48-Week Results From a Single-Arm, Multicenter, Open-Label Phase 3 Study

1 reference

https://api.crossref.org/works/10.1080%2F15284336.2017.1291867

21 January 2018

Efficacy and safety of tenofovir alafenamide versus tenofovir disoproxil fumarate given as fixed-dose combinations containing emtricitabine as backbones for treatment of HIV-1 infection in virologically suppressed adults: a randomised, double-blind,

1 reference

https://api.crossref.org/works/10.1080%2F15284336.2017.1291867

21 January 2018

Clinical practice guideline for the management of chronic kidney disease in patients infected with HIV: 2014 update by the HIV Medicine Association of the Infectious Diseases Society of America

1 reference

https://api.crossref.org/works/10.1080%2F15284336.2017.1291867

21 January 2018

Identifiers

10.1080/15284336.2017.1291867

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28303753%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28303753%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40288176&oldid=1798959383"